" class="no-js "lang="en-US"> Immunology Archives - Page 6 of 11 - Medtech Alert
Friday, October 03, 2025

Sort by:

Date

Top Post

Ai-powered Drug Discovery Company Healx Opens New Labs at Chesterford Research Park

Healx, the AI-powered, patient-inspired technology company pioneering the next generation of drug discovery for rare […]

Athos Therapeutics Announces Research Collaboration to Advance Precision Medicine in Inflammatory Bowel Disease

Athos Therapeutics, Inc. (“Athos”), a late-stage preclinical biotech company using artificial intelligence to develop small […]

ABL Partners With KaliVir Immunotherapeutics to Advance Development of Oncolytic Viruses

ABL, a pure play Contract Development and Manufacturing Organization (CDMO) specialized in the development and […]

Hansa Biopharma Announces First Patient Treated in the Post-authorization Efficacy Study (PAES) of Idefirix® (Imlifidase) in Highly Sensitized Kidney Transplant Patients

Hansa Biopharma AB, “Hansa” (Nasdaq Stockholm: HNSA), pioneer in enzyme technology for rare immunological conditions, […]

Diabetes Patients Set to Benefit From Heart Disease Data Investment

People living with diabetes could be set to benefit from a major research initiative to […]

Researchers Create a Single-cell Framework to Potentially Enhance CAR T-cell Therapy

St. Jude Children’s Research Hospital scientists have demonstrated that the long-term performance of cancer-killing chimeric […]

Skyhawk Announces Collaboration Agreement with Sanofi for Oncology and Immunology Targets

Skyhawk Therapeutics, Inc. today announced the signing of an exclusive worldwide collaboration agreement with Sanofi […]

Enosi Therapeutics Partners with Danuo Science Group to Accelerate Multiple Therapeutic Programs

Enosi Therapeutics, a Delaware Corporation, focused on providing industry-leading therapeutics for cancer and autoimmune diseases, […]

The PanDIA-1 Study, for Early Detection of Pancreatic Cancer in Newly Onset Type 2 Diabetics, Moves Into Next Phase

Immunovia today announced the PanDIA-1 study for the early detection of pancreatic cancer in newly […]

Cepheid and BioGX Announce Collaboration to Develop Monkeypox PCR Test for the GeneXpert® System

Cepheid and BioGX today announced a collaboration between the two companies to deliver a PCR […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more